Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
127 Cards in this Set
- Front
- Back
higher the preload the greater the what?
|
amount of oxygen used by the heart muscles
(myocardial oxygen consumption) |
|
drugs that lower BP leads to sympathetic _______ and parasympathetic ________ via the baroreceptor reflex
|
sympathetic stimulation
parasympathetic inhibition |
|
insensitive baroreceptor mechanisms ________ the BP-lowering actrion of drugs
|
enhance
|
|
major adrenergic receptors involved in BP control
|
alpha1
alpha2 beta1 |
|
_________ are the major determinant of peripheral resistance?
|
arterioles
|
|
protease in the juxtaglomerular cells of the afferent arterioles in the kidney
|
Renin
major determinant of the rate of AII production |
|
Women on birthcontrol pills tend to have an increase in BP due to what?
|
increased synthesis of angiotensinogen
|
|
enzyme located mainly in the endothelial cells of the vasculature; converts AI to AII
|
ACE
aka Kininase II |
|
Factors that stimulate the production and release of renin
|
beta-adrenergic stimulation (SNS activation)
decreased renal perfusion (intrarenal baroreceptor mechanisms) decreased sodium intake prostaglandins |
|
besides the renin-ACE system, AII can also be produced how?
|
chymase
cathepsin chymostain-sensitive AII-generating system tissue plasminogen activator tonin therefore, inhibition of ACE may not completely suppress AII production |
|
what happens to renin levels when the effects of AII are inhibited with an AII-AT1 receptor antagonist?
|
renin levels increase
|
|
AII effects besides vasoconstriction
|
a. ↑ aldosterone synthesis (↑ Na and H2O conservation)
b. ↑ Na, HCO3 reabsorption c. ↑ SNS activity d. ↑Ne and Endothelin-1 release e. ↑ Thirst and vasopressin release f. ↓ Renin release (negative feedback) g. ↑ Filtration allowing protein in urine h. contracts more selectively efferent than afferent arterioles i. ↑ angiogenesis j. plays a role in ovaries and testes (required for normal fetal growth) |
|
mineralocorticoid produced by the adrenal cortex
sodium retaining-potassium, hydrogen, and magnesium ion-loosing hormone |
Aldosterone
-increases number of active sodium channels in the luminal side of cells - increases number of membrane bound Na-K ATPase on the basolateral side -also has important effects on collagen formation and favors clotting |
|
AII retains sodium through what 3 methods?
|
1. increase in aldosterone
2. increases sodium reabsorption on the proximal tubule 3. increases SNS activity |
|
when renal perfusion pressure drops (low BP) the reabsorption of sodium is increased at the _________
|
proximal tubules
|
|
high _____ levels induce salt sensitivity
|
Angiotensin II (AII)
|
|
powerful vasoconstrictor peptide (21 aa) formed in and released from the endothelium
|
Endothelins
|
|
What increases the release of Endothelins?
|
1. AII
2. Hypoxia 3. Stress |
|
______Receptor→ high affinity for ET-1 in vascular muscle causing vasoconstriction
______ Receptor→ same affinity for ET-1 and ET-3 in vascular endothelium leading to NO and prostanoid release |
ETA Receptor→ high affinity for ET-1 in vascular muscle causing vasoconstriction
ETB Receptor→ same affinity for ET-1 and ET-3 in vascular endothelium leading to NO and prostanoid release |
|
ETA Receptor Blockers (ERA)
|
ETA Receptor Blockers (ERA)
Bosaltan Darusentan |
|
Vascular smooth muscle has more or less depolarized resting potential than the skeletal and heart muscle?
|
Vascular smooth muscle has a more depolarized resting potential than the skeletal and heart muscle?
Vascular= -30 Heart Muscle=-70 Important because CCB bind with greater affinity to channels that are inactive/more depolarized CCB have better affect on Vascular smooth muscle Skeletal Muscle relies little on Calcium entry |
|
How do Na/K blockers lower BP?
|
inhibiting Na/K ATPase causes an increase in intracelullar Na
Na/Ca2+ exchanger is then activated allowing Ca2+ in and Na+ out increase in external Ca2+ is what contracts smooth muscle, SA, and AV nodes= increasing HR and constricting vessels |
|
vasodilator produced by the vascular endothelium
|
Nitric Oxide
|
|
Release of NO stimulated by?
|
a. Hypoxia
b. Increased Blood flow c. Bradykinin d. Histamine e. Serotonin f. Arachidonic acid g. ADP/ATP h. Substance P i. Ach j. Thrombin |
|
NO is formed from?
|
l-arginine in the prescence of eNOS (endothelial NO synthase)
|
|
How does Sildenafil (Viagra) work?
|
Sildenafil blocks Phosphodiesterase activity which allows for cGMP not to be destroyed= vasodilation= erection
|
|
arteriolar and venodilator that increases production of cGMP, but can only be given thru IV. Once reacting with hemoglobin it turns into cyanomethemoglobin and cyanide ion and metabolized to thiocyanate; decomposes in light
|
Sodium Nitroprusside
Used for hypertensive emergencies and congestive heart failure |
|
endothelium independent vasodilators that donate NO to tissues
|
Organic Nitrates
(Nitroglicerine, isosorbide dinitrate) Endothelium independent vasodilators |
|
does not induce smooth muscle relaxation via NO- endothelium independent mechanism; PGE2 and PGI2 activate adenylate cyclase increasing intracellular cAMP.
|
Prostaglandin
|
|
what does PGI2 do?
what does Thromboxane do? Whast does Prostaglandin F2 alpha do? |
PGI2→ inhibits platelet aggregation
Thromboxane→ favors platelet aggregation Prostaglandin F2 alpha → vasoconstrictor |
|
peptides with vasodilator action that lower BP by inducing vasodilation and getting rid of water and sodium, inhibit aldosterone secretion and decrease renin secretion
|
Atrial Natriuretic Factors
ANP, BNP, CNP, DNP |
|
ANF vs NO
|
ANF- act by activating membrane-bound guanylate cyclase
NO- diffuse through membrane and acts on cytoplasmic enzyme |
|
What are phosphodiesterases?
|
enzymes that degrade cAMP and cGMP
|
|
Affect of cAMP on:
Skeletal Muscle Heart |
Skeletal Muscle- relaxation
Heart- contraction |
|
What is dyspnea?
|
Shortness of breath
|
|
What is nocturia?
|
high volume of urination at night
|
|
Ranges for:
Normal Pre-Hypertensive Hypertensive |
Normal: <120/<80
Pre-Hypertensive: 120-139/ 80-89 Hypertensive: >140/ >90 |
|
Metabilic syndrome
|
Obesity, hyperlipidemia, elevated glucose, hyperinsulinemia, and hypertension
|
|
more than 11 million americans have both _________ and _________
|
hypertension and diabetes mellitus
|
|
major goal of treatment is to?
|
prevent target-organ damange and to reduce the rate of adverse cardiovascular events
|
|
Normal BP
Pre Stage 1 Stage 2 |
Normal BP: <120/80
Prehypertension: 120-139/ 80-89 Stage 1Hypertension: 140-159/ 90-99 Stage 2 Hypertension: >160/100 |
|
causes for secondary hypertension
|
renal disease
renovascular disease drug-induced hypertension pheochromocytoma endocrine tumors |
|
• First-line drug for uncomplicated essential hypertension
|
Diuretics and beta-blockers
|
|
ACEI are drugs of choice for patients with what conditions?
|
diabetes mellitus
diabetic nephropathy myocardial infarction chronic kidney disease increase risk for coronary artery disease |
|
• Drug used for post MI/Ischemic heart disease
|
Beta-blockers
|
|
• Drugs used for indication for secondary prevention of strokes
|
Diuretics and ACEI
|
|
Elderly and AA are more sensitive to what type of antihypertensive drugs?
|
Diuretics
NOT ACEI, AII-ATi (ARB), renin inhibitors, beta-blockers |
|
Caucasians respond well to?
|
Beta-blockers
|
|
People with high salt diets are less sensitive to what type of HT drug?
|
ACEI
ARB Beta-Blockers |
|
who experiences excessive drop in BP with antihypertensives?
|
Elderly with poor compensatory mechanisms
and patients with low circulating volume |
|
AA and Asians have more complications (cough and angioedema) with what class of HT drugs
|
ACEI
|
|
What is the initial treatment for AA?
|
Thiazide diuretics and/or Calcium Channel blockers
|
|
What should be prescribed for a black or white diabetic with proteinuria?
|
ACEI
low dose of diuretic may be added if initial treatment does not make significant results |
|
Post-M/I patients should be on __________ regardless of his/her race
|
Beta-blocker
|
|
compare alpha 1 antagonists and a selective arterioloar dilator
|
alpha 1 antagonist- decrease both afterload and preload
selective arteriolar dilator- just decreases afterload both lower BP, but alpha antagonist require less myocardial consumption |
|
non-selective beta-blockers inhibit?
|
chronotropic
inotropic vasodilator bronchodilator uterine-relaxing responses to beta-adrenergic stimulation |
|
ISA vs Non-ISA beta blockers
|
ISA= partial agonist
(not indicated for HR reduction, or in patients with angina pectoris) Non-ISA= full antagonist |
|
Non-selective beta-blocker with ISA
Selective beta-Blocker wiht ISA |
Non-selective beta-blocker with ISA- Pindolol and Penbutolol
Selective beta-Blocker with ISA- Acebutolol and Celiprolol |
|
drug of choice for people with peripheral vascular disease?
|
Calcium Channel blockers
|
|
Beta blocker prefered for patients with Asthma or Chronic obstructive pulmonary disease (COPD)
|
Acebutolol
b/c beta-1 antagonist and beta-2 agonist |
|
Beta blockers cover up signs of hypoglycemia except for what?
|
sweating
tachycardia, palpitations, tremor, hunger are all covered up by beta blockers |
|
in general, drugs with vasodilator activity do or do not improve insulin resistance
|
do not change or improve insuline resistance
|
|
epinephrine acting on beta-2 receptors is known to lower _______ by increasing its uptake into the skeletal muscle
|
serum potassium
|
|
Non-selective beta-blocker agents inhibit _____________ ___________
|
Epinephrine-induced hypokalemia
|
|
Name the Beta blockers eliminated by:
Liver Kidney |
Eliminated by Liver→ propranolol, metoprolol, acebutolol
Eliminated by Kidney→ atenolol, nadolol (longest half-life) |
|
commonly used intravenously by hypertensive crisis
|
Labetalol
|
|
Beta blocker with antioxidant activity
also has been shown to reduce mortality by 60% in CHF patients receiving standard treatment with ACEI, diuretics, and digitalis |
Carvedilol
|
|
ETA Receptor Blockers
|
Bosaltan
Darusentan |
|
Na-Ca2+ Channel Blocker
|
Digoxin
|
|
Type V Phosphodiesterase Inhibitor
|
Sildenafil
(destroys Phosphodiesterases which break down cGMP= more cGMP= venodilation=erection) |
|
NO Synthase Inhibitor
|
Dexamethasone
(prevents production of NO) |
|
Organic Nitrates
|
Nitroglicerine
Isosorbide dinitrate (Donates NO to tissue) |
|
Selective α1-Blockers
|
• Prazosin
• Doxazosin • Terazosin • Tamsulosin (uroselective) |
|
Selective α2-Blockers
|
• Yohimbine
|
|
Non-Selective α-Blockers
|
• Phentolamine
• Phenoxybenzamine |
|
Selective β1-Blockers
|
(↓broncho and arteriolar vasoconstriction)
• Atenolol • Metoprolol • Acebutolol (ISA)/ (beta2 agonist) • Betaxolol • Bisoprolol • Celiprolol (ISA) • Nebivolol (↑NO) |
|
Non-Selective β-Blockers
Which ones are ISA and alpha blockers? |
• Propanolol
• Nadolol • Pindolol (ISA) • Penbutolol (ISA) • Levobunolol • Timolol • Carteolol • Carvedilol (alpha blocker) • Labetalol (alpha blocker) |
|
α2 and imidazoline receptor agonists
|
• Clonidine
• Alpha-methyldopa • Guanfacine • Guanabenz • Tizanidin • Monoxidine |
|
Indicated for: hypertensive urgencies and emergencies; fourth-line agent b/c of side effects
|
alpha 2 and imidazoline receptor agonists
|
|
management of opiate detoxification, alcohol, and cigarette withdrawal, for menopausal hot flashes, ulcerative colitis and for spasticity of the skeletal muscle present in multiple sclerosis and following spinal cord trauma
|
Clonidine
|
|
management of increased muscle tone associated with spasticity; acts on presynaptic alpha2 receptors located on the ach-containing nerve terminal of motor neurons innervating the skeletal muscle. Activation of these receptors inhibits ach release producing muscle relaxation (decreased muscle tone)
|
Tizanidine (zanaflex)
|
|
alpha 2 adrenergic agent used for chronic treatment of open angle glaucoma and ocular hypertension; reduces production and increases outflow of aqueous humor; preoperative oral administration of alpha 2 agonists reduces dose requirements for anesthetic and analgesic drugs, decreases preoperative anxiety and induces sedation
|
Brimonidine (alphagan)
|
|
developed specifically for preoperative anxiety and sedation
|
Dexmedetomidine and azepexole
|
|
Side effects of alpha 2 and imidazoline receptor agonists
|
drowsiness, sleepiness, tiredness, dry mouth , constipation; rebound hypertension and withdrawal symptoms if not discontinued gradually;
Alpha-methyldopa→ hemolytic anemia, liver (cholestatic hepatitis) and hematological (neutropenia) disorders |
|
Interactions/ Contraindications of alpha 2 and imidazoline receptor agonists
|
don't use with constipating drug- loperamide, opioids, anticholinergics, antidepressants, verapamil; don't use with tricyclic-antidepressants because they may block the BP lowering effects of clonidine
|
|
activates both α2 and imidazoline receptors located in rostral-ventral medulla
|
Clonidine
|
|
must be converted to its active metabolites (alpha-methyl-NE and alpha-methyl-epinephrine) to exert its antihypertensive effect by activating alpha-2 receptors
|
Alpha-methyldopa
|
|
Sympathetic Nerve Terminal Drugs
|
• Reserpine
• Guanethidine • Guanadrel |
|
lowers BP effectively; only used as last resort for patients with severe, uncontrolled hypertension
|
Guanethidine/ Guanadrel
|
|
affects storage system for catecholamines and serotonin; reduces amount of NE available for release resulting in decreased stimulation of alpha and beta receptors; enters CNS
|
Reserpine
|
|
inhibit NE release from postganglionic sympathetic terminals; both are quaternary amines so do NOT reach CNS
|
Guanethidine & Guanadrel
|
|
Side Effects of Reserpine and Guanethidine/ Guanadrel
|
Reserpine→ tertiary amine so it reaches CNS reducing both peripheral and brain monoamine levels (less NE, EPI, Dopamine, and Serotonin); depression, tiredness, and drowsiness
Guanethidine/ Guanadrel→ dizziness, orthostatic hypotension, retrograde ejaculation, nasal obstruction, fluid retention (Thiazides help reduce incidence of fluid retention and edema) |
|
contraindications with sympathetic nerve terminal drugs (Reserpine, Guanethidine, Guanadrel)
|
don't use with patients with history of depression or if suicidal or breast cancer and/or GI ulcers; don't use with patients with nasal obstruction, orthostatic hypotension, and ejaculatory problems
|
|
Dopamine 1-receptor agonist
|
• Fenoldopam
|
|
management of severe hypertension (up to 48 hours) rapid effects; maximum effects develop within 20-30 minutes
|
Dopamine 1-receptor agonist:
• Fenoldopam |
|
lowers diastolic BP and increases renal perfusion by activating Dopamine-1 receptors; vasodilator; given parenterally to vasodilate peripheral arteries decreasing TPR and acts as diuretic; increases sodium chloride and water excretion); increases renal blood flow
|
Dopamine 1-receptor agonist:
• Fenoldopam |
|
Side effecs of Dopamine 1-receptor agonist:
• Fenoldopam |
headache, flushing, dizziness, tachycardia; not degraded by light
|
|
contraindications for Dopamine 1-receptor agonist:
• Fenoldopam |
Patients with glaucoma because it decreases drainage of aqueous humor
|
|
Thiazides/ thiazide-like
|
• Hydrochlorothiazide (16hr)
• Bendroflumethiazide • Chlorothiazide • Polythiazide • Chlorthalidone (24hr) • Indapamide • Xipamide • Metolazone (okay with renal failure) |
|
inhibits reabsorption of NaCl on the cortical portion of thick ascending limb of Henle
|
Thiazides/ thiazide-like
|
|
Loop diuretics
|
• Furosemide (12hr)
• Bumetanide • Torsemide • Piritanide • Ethacrinic acid |
|
reduce NaCl reabsorption in the thick ascending limb of Henle by inhibiting the Na-K-2Cl symport
|
Loop Diuretics
|
|
used when hypertension is associated with edematous states (sodium retention, CHF) or when renal dysfunction is present; synergistic diuretic interaction between thiazides and loop diuretics
|
Loop Diuretics
|
|
Potassium-Sparing diuretics
|
• Triamterene
• Amiloride • Spironolactone • Eplerenone |
|
inhibitors of the renal epithelial sodium channels block sodium channels present in the luminal membrane of principal cells in the late distal tubule and collecting ducts
|
Triamterene and Amiloride
|
|
aldosterone antagonists reduce aldosterone mediated increased synthesis, distribution and activation of sodium channels and of membrane bound sodium-potassium ATPase of principal cells in the late distal and collecting ducts. Reduces number of sodium channels or blocks the channels inhibiting sodium reabsorption
|
Spironolactone and Eplerenone
|
|
Used in combination with other diuretics to avoid or reverse hypokalemia; reduces the loss of potassium, hydrogen ion, and magnesium induced by thiazides and loop diuretics; weaker diuretics than loop diuretics
|
Potassium-Sparing diuretics
|
|
alternative to thiazides in patients with low potassium, hyperuricemia, glucose intolerance and/or the presence of high aldosterone levels; used to treat hirsutism in females
|
Spironolactone
|
|
Which Diuretics is best for patients with renal failure (serum creatine greater than 2.5 mg/dl) but want to prevent hyperkalemia?
NSAIDS and steroids may increase the risk of hyperkalemia in which diuretics? |
Potassium-Sparing diuretics
|
|
Which diuretic is good to use if patient has:
hypokalemia, ↑serum uric acid and gout, hyperglycemia, hyperlipidemia, ↑or↓ in Ca2+, sexual function, erectile dysfunction, decreased libido, delay in orgasm, ↓lithium clearance, and ↑serum lithium levels |
Potassium-Sparing diuretics
|
|
interferes with testosterone synthesis and may increase conversion of testosterone to estradiol; endocrine abnormalities; gynecomastia
|
Spironolactone
|
|
may cause hyperkalemia; does not have endocrine side effects like Spironolactone
|
Eplerenone
|
|
Low salt intake ________ effects of diuretics; high salt diet _____ the potassium-loosing effect of diuretics
|
Low salt intake enhances effects of diuretics; high salt diet accentuates the potassium-loosing effect of diuretics
|
|
Hypokalemia is known to potentiate the effects of __________
|
Hypokalemia is known to potentiate the effects of digoxin
|
|
Hypokalemia should be avoided in patients with
|
• hypertension
• diabetes • ischemic heart disease • arrhythmia • CHF • taking antiarrhythmic drugs • taking digoxin • taking beta-2 agonists |
|
Preferred in patients with renal impairment
|
Loop Diuretics
|
|
Not effective in patients with renal impairment
|
Thiazide Diuretics
|
|
thiazide-type diuretic that retains efficacy in renal failure; used with small doses with furosemide in hypertensives with renal disease
|
Metolazone
|
|
______ stimulation to the kidney induces the release of renin via stimulation of beta receptors?
|
Sympathetic
|
|
What does Aldosterone do?
|
1. sodium retaining
2. K, H, and Mg loosing 3. collagen formation 4. favors clotting AKA repair-promoting substance |
|
What induces salt sensitivity?
|
High levels of AII
|
|
Compare NE, AII, and Endothelins as vasocontrictors
|
ET-1>>> AII>>NE
|
|
ETA vs ETB receptors
|
ETA→ vascular smooth muscle; vasoconstriction
ETB→vascular endothelium; release NO and prostanoids (vasodilation) |
|
What do CCB do to the ECG?
|
prolongs the PR interval
|
|
Name 4 ways to modulate intracellular Ca2+
|
1. Voltage-dependent calcium channel (CCB)
2. Cell membrane Ca2+ pump 3. Na+/Ca2+ exchanger (Digoxin) 4. Sarcoplasmic Reticulum and Mitochondria (IP3) |
|
How does NO cause vasodilation?
|
NO passes from the endothelium to the smooth muscle, where it stimulates cGMP production, which in turn leads to vasodilation
NO also reduces platelet adhesion and aggregation; inhibits adherence of platelets, WBC, and LDL-C to the endothelium |
|
What is the max daily intake of Salt?
What other supplement can you take to help lower your BP? |
Max Salt Intake= 6 grams/day
Increasing Potassium intake can lower BP |